INTRODUCTION {#SEC1}
============

The toxin-antitoxin (TA) system in bacteria is an acquired strategy required for growth and survival in various environments. The bacterial TA module is a gene pair of a toxin and an antitoxin encoded within an operon ([@B1]). Proteinaceous toxins inhibit various pivotal cellular processes, such as DNA synthesis, protein synthesis and cell wall synthesis, and thereby repress and/or regulate bacterial growth. Antitoxins are RNAs or proteins that neutralize the toxin activities, by repressing the toxin expression or inhibiting the toxin activity under normal physiological conditions. The TA system is divided into six classes (types I--VI), based on the properties of the antitoxin ([@B4]). In the type II TA system, proteinaceous antitoxins repress the activity of the toxins through protein-protein interactions. Under normal environmental conditions, the antitoxin forms a tight complex with the cognate toxin, thus masking the toxin activity. When bacteria encounter environmental stresses, such as nutrient starvation or antibiotic exposure, the antitoxins are degraded by proteinases, such as Lon and ClpP ([@B5]). As a result, the masking of the toxin activities by the antitoxin is released and the bacteria repress their own growth ([@B3],[@B6]).

Recently, a new type II toxin that belongs to the GNAT (Gcn5-related *N*-acetyltransferase) family was identified ([@B9]). These GNAT family toxins catalyze the acetylation of the α-amino group of the aminoacyl-moiety of aminoacyl-tRNAs, using acetyl-CoA as an acetyl group donor. TacT, TacT2 and TacT3 from *Salmonella enterica* Typhimurium acetylate various aminoacyl-tRNAs and inhibit overall protein synthesis, and their activities are associated with intracellular persistence in macrophages ([@B9],[@B14]). A recent analysis showed that TacT, TacT2 and TacT3 acetylate different sets of aminoacyl-tRNA species *in vitro* ([@B14]). AtaT from the enterohemorrhagic *Escherichia coli* O157:H7 strain specifically acetylates initiator methionyl-tRNA^Met^ (Met-tRNAf^Met^) *in vitro*, and it may also inhibit the initiation step of protein synthesis by blocking the interaction with the initiator factor ([@B10],[@B15],[@B16]). GmvT from the *Shigella sonnei* pINV plasmid ([@B12]) and KacT from *Klebsiella pneumoniae* ([@B13],[@B17],[@B18]) are also GNAT family toxins, and may acetylate aminoacyl-tRNAs and inhibit protein synthesis, although their target aminoacyl-tRNAs have not been clarified. ItaT, recently identified from the *E. coli* HS strain, specifically acetylates isoaccepting isoleucyl-tRNA^Ile^s (Ile-tRNA^Ile^) and inhibits protein synthesis *in vitro* ([@B11]). While a number of GNAT family toxins targeting aminoacyl-tRNAs have been identified from various organisms over the last few years, as described above, the molecular mechanism of the aminoacyl-tRNA recognition and the specificities of the GNAT family toxins have remained elusive.

Here, we present functional and structural analyses of ItaT, Ile-tRNA^Ile^ acetyltransferase toxin, from *E. coli* HS ([@B11]). We show that, in addition to Ile-tRNA^Ile^, Val-tRNA^Val^ and Met-tRNA^Met^ are acetylated by ItaT *in vivo* and *in vitro*. Neither Leu-tRNA^Leu^, Ala-tRNA^Ala^ nor Phe-tRNA^Phe^ is significantly acetylated by ItaT. Thus, the ItaT toxin has broader specificity toward aminoacyl-tRNAs charged with certain hydrophobic amino acids. We also identified a hydrophobic pocket in the ItaT structure for aminoacyl moiety recognition. Comparisons of the side chain structures of the aminoacyl moieties of substrate aminoacyl-tRNAs suggest that the size, shape, and hydrophobicity of the pocket in the vicinity of the catalytic site of ItaT select a specific group of aminoacyl-tRNAs for acetylation.

MATERIALS AND METHODS {#SEC2}
=====================

Plasmid constructions {#SEC2-1}
---------------------

The DNA fragment encoding the *E. coli* HS *itaRT* module ([@B11]), the *itaR*-*itaT* operon, was purchased from Eurofins, Japan. The synthesized nucleotide sequence is shown in [Supplementary Table S1](#sup1){ref-type="supplementary-material"}. For ItaR-ItaT complex overexpression in *E. coli*, the *itaR-itaT* operon sequence was cloned between the NdeI and XhoI sites of the pET22b vector (Merck Millipore, Japan), yielding the plasmid pET22b-ItaRT. The ItaT in the complex has a hexahistidine tag at the C-terminus. To obtain the plasmid for the expression of the inactive ItaT (G115D) mutant protein, the G115D mutation was introduced into pET22b-ItaRT by the overlap PCR method, and then the *itaT* coding DNA bearing the G115D mutation was PCR amplified and cloned into the *Nde*I and *Xho*I sites of pET-22b, yielding pET22b-ItaT(G115D). For the evaluation of the toxicity of ItaT *in vivo*, the DNA fragment containing the *itaT* sequence was PCR amplified from pET22-ItaRT and cloned between the NdeI and HindIII sites of the pBAD33 vector, purchased from ATCC (ATCC^®^ 87402^™^), yielding the plasmid pBAD33-ItaT. To obtain the plasmids containing *itaT* variants, the mutations were introduced by the overlap PCR method using pBAD33-ItaT as the template. The oligonucleotide sequences used for the plasmid constructions are listed in [Supplementary Table S2](#sup1){ref-type="supplementary-material"}.

Expression and purification of ItaT and its variants {#SEC2-2}
----------------------------------------------------

*Escherichia coli* BL21(DE3) (Novagen-Merck Millipore) was transformed with pET-22b-ItaT(G115D), pET22b-ItaRT or its variants and grown in LB medium containing 50 μg/ml ampicillin at 37°C until the OD~660~ reached 0.5. The expression of ItaT(G115D), the ItaR-ItaT complex and its variants was induced by adding IPTG (isopropyl-β-[d]{.smallcaps} thiogalactopyranoside) at a final concentration of 0.1 mM and continuing the culture for 20 h at 20°C. The harvested cells were sonicated in buffer, containing 20 mM Tris--HCl, pH 7.0, 500 mM NaCl, 5 mM β-mercaptoethanol, 10 mM imidazole, 50 μg/ml lysozyme and 0.1 mM PMSF (phenylmethylsulfonyl fluoride), and the lysate was centrifuged. The supernatant was first applied to a Ni-NTA agarose column (Qiagen, Japan). The column was washed with buffer, containing 20 mM Tris--HCl, pH 7.0, 500 mM NaCl, 5 mM β-mercaptoethanol, and 10 mM imidazole, and the protein was eluted from the column with buffer containing 20 mM Tris--HCl, pH 7.0, 500 mM NaCl, 5 mM β-mercaptoethanol and 250 mM imidazole. The proteins were further purified using a HiTrap Heparin column (GE Healthcare, Japan), and finally purified on a HiLoad 16/60 Superdex 200 column (GE Healthcare, Japan) equilibrated with buffer containing 20 mM Tris--HCl, pH 7.0, 500 mM NaCl and 10 mM β-mercaptoethanol.

For purification of the wild-type ItaT (or its variants) and the ItaR--ItaT complex (or its variant complexes) we first used a Ni-NTA agarose column and a HiTrap Heparin column, as described above. The ItaR-ItaT complex (or its variant complexes) was loaded onto a Ni-NTA column and denatured by adding denaturing buffer (8 M urea, 20 mM Tris-HCl, pH 8.0, 500 mM NaCl and 5 mM β-mercaptoethanol). ItaT (or its variants) with a C-terminal histidine tag was retained on the column, and ItaR was washed out from the column. The denatured ItaT (or its variants) was refolded with a stepwise concentration gradient of urea (6, 4, 2, 1, 0.5 and 0 M) on the column. Finally, ItaT was eluted from the column with buffer containing 50 mM Tris--Cl, pH 7.0, 500 mM NaCl, 10 mM β-mercaptoethanol, 10% (v/v) glycerol and 400 mM imidazole, and further purified on a Heparin Sepharose 6 Fast Flow column (GE Healthcare, Japan).

Preparation of aminoacyl-tRNA synthetases {#SEC2-3}
-----------------------------------------

The DNA fragment encoding the *E. coli* isoleucyl-tRNA synthetase (IleRS) gene was PCR amplified from the genomic DNA and cloned between the NdeI and XhoI sites of the pET-22b plasmid. The primers used for the PCR are listed in [Supplementary Table S2](#sup1){ref-type="supplementary-material"}. The IleRS protein was expressed in *E. coli* BL21(DE3), and the overexpressed IleRS was purified by chromatography on Ni-NTA and HiTrap Heparin columns, as described above. Finally, the IleRS protein was purified on a HiLoad 16/60 Superdex 200 column, in buffer containing 20 mM Tris--HCl, pH 7.0, 200 mM NaCl and 10 mM β-mercaptoethanol. Methionyl-tRNA synthetase (MetRS) was prepared as described previously ([@B16]). The plasmids for the overexpression of other aminoacyl-tRNA synthetases (ARSs: AlaRS, ValRS, LeuRS and PheRS) were kind gift from Dr Shimizu (RIKEN, Japan), and the proteins were prepared in the same manner as described above.

Preparation of tRNAs {#SEC2-4}
--------------------

The synthetic DNA fragments of the *E. coli* tRNA^Leu^, tRNA^Ala^ and tRNA^Phe^ genes were inserted between the SacI and PstI sites of the pBSTNAV3 plasmid ([@B19]). The pBSTNAV3 plasmids encoding tRNAfMet, tRNAmMet, tRNA^Val^ and tRNA^Ile^ were described previously ([@B20],[@B21]). The nucleotide sequences of these tRNA genes encoding tRNA^Phe^, tRNA^Ala^ and tRNA^Leu^ are listed in [Supplementary Table S1](#sup1){ref-type="supplementary-material"}. The *E. coli* JM101Tr ([@B22]) strain was transformed by the pBSTNAV3 plasmid encoding the respective gene and cultured in 2× YT medium containing 50 μg/ml ampicillin, at 37°C for 24 h. The total tRNA fraction was prepared as described, with modifications ([@B20],[@B21]). After the deacylation of the amino acyl-tRNAs, total RNAs were dissolved in buffer containing 20 mM Tris--Cl, pH 7.4, 0.1 mM EDTA, and 8 mM Mg(OAc)~2~, loaded on a HiLoad 16/10 Q-Sepharose HP column (GE Healthcare, Japan) and separated by a linear NaCl gradient (0.2--1.0 M) in the buffer. The tRNA^Ile^, tRNAf^Met^, tRNAm^Met^, tRNA^Val^, tRNA^Ala^, tRNA^Leu^ or tRNA^Phe^ enriched fractions were detected by the aminoacylation activity, using the respective cognate aminoacyl-tRNA synthase and radiolabeled amino acid, pooled and ethanol-precipitated.

The tRNA fractions prepared as described above were aminoacylated by their cognate aminoacyl-tRNA synthetases, and the amounts of the enriched isoacceptor tRNAs in the respective tRNA fractions were measured. For estimations of the tRNA^Ile^ isoacceptors in the tRNA preparation, the reaction mixture (10 μl volume), containing 20 mM Tris--HCl, pH 7.4, 150 mM KCl, 7 mM MgCl~2~, 10 mM ATP, 10 mM β-mercaptoethanol, 9.4 μM tRNA preparation, 180 μM [l]{.smallcaps}-\[methyl-^14^C\]-isoleucine (50 Ci/mol; American Radiolabeled Chemicals, Inc.), and 1 μM isoleucyl-tRNA synthetase (IleRS), was incubated at 37°C for 30 min. An aliquot (9 μl) was spotted onto a Whatman 3MM filter (GE Healthcare, Japan) and the radioactivities on the filters were quantified with a liquid scintillation counter (Hitachi-Aloka Medical), as described ([@B23]). For the estimation of other tRNA isoacceptors in each tRNA preparation, the cognate purified aminoacyl-tRNA synthetase and amino acid were used for the reaction.

*In vitro* acetylation assay {#SEC2-5}
----------------------------

First, a reaction mixture (15 μl volume), containing 20 mM Tris--HCl, pH 7.4, 150 mM KCl, 7 mM MgCl~2~, 10 mM β-mercaptoethanol, 2.7 mM ATP, 8.8 μM each tRNA isoacceptor in the respective preparation, 250 μM cognate amino acid and 1 μM cognate aminoacyl-tRNA synthetase, was incubated at 37°C for 1 h. Afterwards, a 15 μl portion of the next reaction mixture, containing 100 μM \[acetyl-1-^14^C\]-acetyl Coenzyme A (acetyl-CoA, 60 Ci/mol, Perkin Elmer, Japan) and 0.2 μM ItaT (or its variants), was added and incubated at 37°C. An aliquot (9 μl) was spotted onto a Whatman 3MM filter at the indicated time, and the radioactivities on the filters were measured as described above.

*In vivo* toxicity assay for itaT and its variants {#SEC2-6}
--------------------------------------------------

*Escherichia coli* strain MG1655, purchased from NBRB *E. coli* strain (NIG, Japan) was transformed with pBAD33-ItaT or its variants, inoculated in LB containing 50 μg/ml chloramphenicol in the presence of 0.5% (w/v) glucose, and cultured at 37°C. To evaluate the toxicities of ItaT in liquid medium, the overnight cultures were diluted to an OD~660~ of 0.03 in fresh liquid LB containing 50 μg/ml chloramphenicol, supplemented with either 0.1% (w/v) glucose or 0.1% (w/v) arabinose. The cultures were continued at 37°C, and the OD~660~ values of the cultures were measured. To evaluate the toxicities of ItaT and its variants by the spot assay, the overnight LB cultures were serially diluted, and 3 μl portions were spotted on LB agar plates containing 50 μg/ml chloramphenicol, supplemented with either 0.1% (w/v) glucose or 0.1% (w/v) arabinose, and then the plates were incubated overnight at 37°C.

Crystallization and structural determination of ItaT {#SEC2-7}
----------------------------------------------------

For crystallization of the ItaT(G115D) protein, 0.2 μl of the protein solution (2 mg/ml) was mixed with 0.2 μl of reservoir solution, containing 100 mM Tris--HCl, pH 7.6, 30 mM sodium citrate, and 26% (v/v) PEG3350, and the crystals were generated by the hanging drop vapor diffusion method at 20°C. Data sets were collected on beamline 17A at the Photon Factory at KEK, Japan. The crystals were flash cooled in 1.1× concentrated reservoir solution, supplemented with 30% (v/v) ethylene glycol as a cryoprotectant. The data were indexed, integrated, and scaled with XDS ([@B24]). The homology model structure of ItaT was built by the SWISS-MODEL server ([@B25]) using the *K. pneumoniae* KacT structure ([@B18]), and the initial phase was determined by the molecular replacement method, using the homology model as the search model, by Phaser. The structure was refined with phenix.refine ([@B26]), and manually modified with Coot ([@B27]).

Preparation of acetylated aminoacyl-tRNAs from *E. coli* upon induction of ItaT {#SEC2-8}
-------------------------------------------------------------------------------

*Escherichia coli* strain MG1655 was transformed with either pBAD33-ItaT or empty pBAD33 and cultured overnight. The overnight cultures were diluted to an OD~660~ of 0.03 into fresh liquid LB (3 ml) containing 50 μg/ml chloramphenicol, and the cultures were continued at 37°C until the *A*~660~ reached 0.2. At this point, 0.02% (w/v) arabinose was added. At 15 min after inoculation, the cells were harvested, and suspended in buffer containing 50 mM NaOAc, pH 5.0, 0.5 mM EDTA and 0.2 M NaCl. The RNA was extracted by phenol saturated with 300 mM NaOAc, pH 5.2, followed by isopropyl alcohol precipitation. The RNA was dissolved in 250 μl of cold 200 mM NaOAc, pH 5.0, and acetylated by adding acetic anhydride-D~6~ (Sigma Aldrich, Japan) as described ([@B28]). Afterwards, the RNA was ethanol precipitated and rinsed with 70% cold ethanol. The RNA was dissolved in cold buffer containing 50 mM NaOAc, pH 5.0, 0.5 mM EDTA and 0.2 M NaCl, and loaded onto 100 μl of Q-Sepharose FF (GE Healthcare, Japan). The resin was washed with buffer containing 50 mM NaOAc, pH 5.0, 0.5 mM EDTA and 0.2 M NaCl. The tRNA was eluted with buffer containing 50 mM NaOAc, pH 5.0, 0.5 mM EDTA and 0.6 M NaCl, ethanol precipitated and rinsed with 70% ethanol. The pellet was dissolved in 2 mM NaOAc, pH 5.0.

LC/MS spectrometry {#SEC2-9}
------------------

The purified acetylated aminoacyl-tRNAs described above were digested with RNase One Ribonuclease (Promega, Japan), in a reaction mixture (25 μl volume) containing 25 mM NH~4~OAc and 2.5 units enzyme, at 37°C for 60 min. The digests were subjected to an LC/MS analysis using a Q Exactive Hybrid Quadrupole-Orbitrap Mass Spectrometer (Thermo Fisher Scientific), equipped with a Dionex UltiMate 3000 LC System (Thermo Fisher Scientific) and an SunShell C18 column (2.6 μm, 2.1 × 150 mm, ChromaNik Technologies Inc.). Elution was carried out at flow rate of 0.075 ml/min using multi-linear gradient with 5 mM ammonium acetate (pH 5.3) (solvent A) and 100% acetonitrile (Fuji Film) (solvent B). The following gradient was used:0-30% B from 0--40 min; 30--80% B from 40--41 min; 80% B from 41--46 min; 80-0% B from 46--47 min; and 0% B from 47--60 min. Ions were scanned by the use of the positive polarity mode over an *m/z* range of 110--950 ([@B29]).

RESULTS {#SEC3}
=======

Induction of ItaT *in vivo* is toxic {#SEC3-1}
------------------------------------

Recently, *E. coli* ItaT, [i]{.ul}soleucyl-[t]{.ul}RNA [a]{.ul}cetyltransferase [t]{.ul}oxin, was reported to acetylate the α-amino group of the aminoacyl moiety of isoleucyl-tRNA^Ile^*in vitro*, in good accordance with its name ([@B11]). To verify the aminoacyl-tRNA substrates of ItaT *in vivo*, the ItaT toxin was expressed in *E. coli* using the pBAD expression system, in which the expression of ItaT can be tightly controlled by adding arabinose, and the aminoacyl-tRNAs in the cells were analyzed by LC/MS spectrometry. The induction of ItaT toxin in *E. coli* suppresses cell growth on an agar plate (Figure [1A](#F1){ref-type="fig"}), and in the liquid medium, after the induction of ItaT toxin, the growth of cells bearing the ItaT expression plasmid was suppressed due to the toxicity of ItaT (Figure [1B](#F1){ref-type="fig"}).

![Induction of ItaT*in vivo* is toxic. (**A**) The killing activity of ItaT *in vivo*. Overnight cultures of *E. coli* MG1655 transformed with pBAD33 and pBAD33-ItaT were serially diluted, and the dilutions were spotted on LB agar plates containing 50 μg/ml chloramphenicol supplemented with 0.1% (w/v) arabinose (lower panel) or without arabinose (upper panel). The plates were incubated at 37°C. (**B**) Growth curves of *E. coli* MG1655 transformed with pBAD33 and pBAD33-ItaT. Induction of ItaT by the addition of 0.1% (w/v) arabinose suppresses the growth of *E. coli* harboring pBAD33-ItaT in LB containing 50 μg/ml chloramphenicol. When the OD~660~ reached 0.2, arabinose was added to the medium and the culture was continued at 37°C. The arrow in the graph indicates the induction of ItaT by arabinose addition.](gkaa487fig1){#F1}

Acetylation of aminoacyl-tRNAs by ItaT *in vivo* {#SEC3-2}
------------------------------------------------

To analyze the aminoacyl-tRNA species acetylated by ItaT *in vivo*, after ItaT induction in *E. coli*, the RNA fraction was immediately prepared from the cells, under acidic and cold conditions to avoid the hydrolysis of aminoacyl-tRNAs (aa-tRNAs) and acetylated aminoacyl-tRNAs (Ac-aa-tRNAs) produced by ItaT *in vivo*. The purified RNA fraction was subsequently treated with stable isotopic acetic anhydride-D~6~ \[(CD~3~CO)~2~O; D is deuterium\], to chemically convert the remaining aa-tRNAs (i.e. aa-tRNAs not acetylated by ItaT *in vivo*) to D~3~-acetyl aminoacyl-tRNAs (D~3~Ac-aa-tRNAs) *in vitro*. The RNAs were then digested with RNase I, and the amounts of Ac-aa-A76 (A76 is the 3′-terminal adenosine of the tRNA molecule) and D~3~Ac-aa-A76 in the digests were quantified by LC/MS spectrometry. The scheme of the analysis is depicted in Figure [2A](#F2){ref-type="fig"}.

![Acetylation of Ile-tRNA^Ile^, Val-tRNA^Val^ and Met-tRNA^Met^ isoacceptors *in vivo*. (**A**) Schematic diagram of detection and quantification of acetyl-aminoacyl-tRNAs, produced by the action of ItaT *in vivo* (See details in Materials and Methods). (**B**) LC/MS analysis of RNase I-digested fragments of acetyl-aminoacyl-tRNAs. Identification of the molecular masses corresponding to Ac-Ile/Leu-A76 (acetyl-isoleucyl/leucyl-adenosine, m/z 423.19), Ac-Val-A76 (acetyl-valyl-adenosine, *m*/*z* 409.18) and Ac-Met-A76(acetyl-methionyl-adenosine, *m*/*z* 441.15) derived from Ac-Ile/Leu-tRNA^Ile/Leu^, Ac-Val-tRNA^Val^ and Ac-Met-tRNA^Met^, respectively, produced by the action of ItaT *in vivo*. Ac-Ala-A76 (acetyl-alanyl-adenosine) and Ac-Phe-A76 (acetyl-phenylalanyl-adenosine) were not detected. Identification of the molecular masses corresponding to D~3~Ac-Ile/Leu-A76 (*m/z* 426.21), D~3~Ac-Val-A76 (*m/z* 412.20), D~3~Ac-Met-A76 (*m/z* 444.17), D~3~Ac-Ala-A76 (*m/z* 384.17) and D~3~Ac-Phe-A76 (*m/z* 460.20), derived from the *in vitro* aminoacyl-tRNAs chemically acetylated by acetic anhydride-D~6~. The two observed peaks in each Ac-aa-A76 represent structural isomers of 3′-acetyl-aminoacyl-A76 and 2′-acetyl-aminoacyl-A76, as observed for the separation of 3′-O-methyl and 2′-O-methyl nucleosides ([@B38]). (**C**) Quantification of the acetylation of aminoacyl-tRNAs by the action of ItaT *in vivo*. The fractions of individual acetylated aminoacyl-tRNAs by ItaT *in vivo* were estimated as the ratio of the amount of Ac-aa-A76 to the sum of the amounts of Ac-aa-A76 and D~3~Ac-aa-A76. The bars in the graphs are SD of more than three independent experiments.](gkaa487fig2){#F2}

The LC/MS analyses of RNase I-digested RNAs prepared from cells with ItaT induction revealed the molecular masses corresponding to acetyl isoleucyl (or leucyl)-adenosine (Ac-Ile/Leu-A76, *m*/*z* = 423.19), acetyl valyl-adenosine (Ac-Val-A76, *m*/*z* = 409.18), and acetyl methionyl- adenosine (Ac-Met-A76, *m*/*z* = 441.15) (Figure [2B](#F2){ref-type="fig"}). In the RNA preparation from control *E. coli* harboring the empty pBAD33 vector, the molecular masses corresponding to these Ac-aa-A76 molecules (aa: Ile/Leu, Val or Met) were not observed. These results suggested that Ile/Leu-tRNA^Ile/Leu^ (Ile-tRNA^Ile^ or Leu-tRNA^Leu^), Val-tRNA^Val^ and Met-tRNA^Met^ are acetylated by the action of ItaT *in vivo*. The molecular masses corresponding to acetyl alanyl-adenosine (Ac-Ala-A76, *m*/*z* = 381.15) and acetyl phenylalanyl-adenosine (Ac-Phe-A76, *m*/*z* = 457.18) were barely detectable, suggesting that Ala-tRNA^Ala^ and Phe-tRNA^Phe^ are not acetylated by ItaT *in vivo* (Figure [2B](#F2){ref-type="fig"}).

The molecular masses corresponding to D~3~Ac-Ile/Leu-A76 (*m*/*z* = 426.21), D~3~Ac-Val-A76 (*m*/*z* = 412.2), and D~3~Ac-Met-A76 (*m*/*z* = 444.17), which are derived from their respective aa-tRNAs acetylated by acetic anhydride-D~6~*in vitro*, were quantified (Figure [2B](#F2){ref-type="fig"}). The fractions of individual aminoacyl-tRNAs acetylated by ItaT *in vivo* were estimated as the ratio of the amount of Ac-aa-A76 to the sum of the amounts of Ac-aa-A76 and D~3~Ac-aa-A76 in the ItaT induced cells. Among the twenty kinds of aminoacyl-tRNAs ([Supplementary Figure S1](#sup1){ref-type="supplementary-material"}), significant fractions of Ile/Leu-tRNA^Ile/Leu^ (Ile-tRNA^Ile^ or Leu-tRNA^Leu^), Val-tRNA^Val^ and Met-tRNA^Met^ were acetylated *in vivo* by the action of ItaT (Figure [2C](#F2){ref-type="fig"}). For Ile/Leu-tRNA^Ile/Leu^, we could not definitely determine whether Ile-tRNA^Ile^ or Leu-tRNA^Leu^ or both are acetylated by ItaT *in vivo*, since isoleucine and leucine are structural isomers. However, about 60% of the Ile/Leu-tRNA^Ile/Leu^ isoacceptors in the cells are estimated to be acetylated by the action of ItaT *in vivo* (Figure [2C](#F2){ref-type="fig"}). As described below, since Ile-tRNA^Ile^ is acetylated by ItaT more efficiently than Leu-tRNA^Leu^*in vitro*, over 60% of the Ile-tRNA^Ile^ isoacceptors in the cells would be acetylated by the action of ItaT *in vivo*. For Val-tRNA^Val^, about 80% of the Val-tRNA^Val^ isoacceptors in the cells are acetylated by the action of ItaT *in vivo*. For Met-tRNA^Met^, in addition to the molecular mass corresponding to Ac-Met-A76, the molecular mass corresponding to N-formyl methionyl adenosine (fMet-A76, *m*/*z* = 427.13) was observed in the RNA preparation from both ItaT-induced and control *E. coli* ([Supplementary Figure S2A](#sup1){ref-type="supplementary-material"}).When the intensity of fMet-A76 in each sample is expressed relative to the intensity of D~3~Ac-Phe-A76 or D~3~Ac-Gly-A76 in the sample, the intensities of fMet-A76 are not significantly changed (Figure [2B](#F2){ref-type="fig"}). This observation suggests that the amounts of fMet-tRNAf^Met^ in the cells are not significantly altered by the action of ItaT induction *in vivo*. Thus, about 60% of the remaining Met-tRNA^Met^ isoacceptors in the cells are estimated to be acetylated by the action of ItaT *in vivo*.

Acetylation of aminoacyl-tRNAs by ItaT *in vitro* {#SEC3-3}
-------------------------------------------------

The analyses of the aminoacyl-tRNA species acetylated by the action of ItaT *in vivo* (Figure [2](#F2){ref-type="fig"}) suggest that ItaT acetylates Val-tRNA^Val^ and Met-tRNA^Met^ in addition to Ile-tRNA^Ile^ isoacceptors. To confirm the results obtained by the *in vivo* analyses, the acetylation of various aminoacyl-tRNAs by ItaT was analyzed *in vitro* (Figure [3](#F3){ref-type="fig"}). In the analyses, prior to the acetylation by ItaT, the concentration of each aminoacyl-tRNA was adjusted so the same amounts of aminoacyl-tRNAs were used for the assays. The results showed that in addition to Ile-tRNA^Ile^ isoacceptors, Val-tRNA^Val^ and Met-tRNA^Met^s (methionyl initiator tRNA^Met^; Met-tRNAf^Met^ and methionyl elongator tRNA^Met^: Met-tRNAm^Met)^ isoacceptors were significantly acetylated (Figure [3A](#F3){ref-type="fig"}). The acetylation efficiencies of the aminoacyl-tRNAs, calculated from the initial velocities of acetylation, revealed that Val-tRNA^Val^ isoacceptors and Met-tRNAf^Met^ are acetylated efficiently to extents of 30--40% of Ile-tRNA^Ile^, and Met-tRNAm^Met^ is acetylated to an extent of about 20% of the Ile-tRNA^Ile^ isoacceptors *in vitro* (Figure [3B](#F3){ref-type="fig"}). On the other hand, Leu-tRNA^Leu^ isoacceptors are acetylated by ItaT to an extent of less than 10% of Ile-tRNA^Ile^ isoacceptors. Thus, as described above, the molecular mass corresponding to the Ac-Ile/Leu-A76 observed by the mass spectrometric analysis of the RNA digests prepared from Ita-T-induced *E. coli* (Figure [2A](#F2){ref-type="fig"}) would be derived mostly from the Ac-Ile-tRNA^Ile^ isoacceptors, rather than the Ac-tRNA^Leu^ isoacceptors.

![Acetylation of Ile-tRNA^Ile^, Val-tRNA^Val^ and Met-tRNA^Met^ isoacceptors *in vitro*. (**A**) Time courses of the acetylations of Ile-tRNA^Ile^ (Ile), Val-tRNA^Val^ (Val), Met-tRNAf^Met^ (f-Met: methionyl-initiator tRNA^Met^), Met-tRNAm^Met^ (m-Met: methionyl-elongator tRNA^Met^), Leu-tRNA^Leu^ (Leu), Ala-tRNA^Ala^ (Ala) and Phe-tRNA^Phe^ (Phe) by ItaT *in vitro*. (**B**) Quantification of the acetylation efficiencies of various aminoacyl-tRNAs in (A) by ItaT *in vitro*. The initial velocities of the acetylation of aminoacyl-tRNAs were calculated. The graph shows the relative acetylation efficiencies of the tested aminoacyl-tRNAs. The acetylation efficiency of Ile-tRNA^Ile^ isoacceptors was taken as 1.0. The bars in the graphs are SD of more than three independent experiments. (**C**) Chemical structures of amino acids, Ile, Val, Met, Leu, Phe and Ala. The shaded groups on the side chains of Leu and Phe would sterically clash with the amino acid residues in the aminoacyl moiety binding pocket of ItaT (see Discussion).](gkaa487fig3){#F3}

Since the side chains of isoleucine, valine and methionine are hydrophobic, we further tested the acetylation of other aminoacyl-tRNAs charged with hydrophobic amino acids, such as alanine and phenylalanine, by ItaT *in vitro* (Figure [3C](#F3){ref-type="fig"}). The results showed that the Ala-tRNA^Ala^ and Phe-tRNA^Phe^ isoacceptors are acetylated to extents less than 10% of that of Ile-tRNA^Ile^ (Figure [3A](#F3){ref-type="fig"}, [B](#F3){ref-type="fig"}). These *in vitro* analyses are consistent with the *in vivo* observations, in which the fractions of acetylated Ala-tRNA^Ala^ and Phe-tRNA^Phe^ isoacceptors were less than 5% of the total Ala-tRNA^Ala^ and Phe-tRNA^Phe^, respectively, *in vivo* when ItaT is induced (Figure [2B](#F2){ref-type="fig"}, [C](#F2){ref-type="fig"}). Altogether, the size and shape of the hydrophobic side chain of the aminoacyl-moiety of aminoacyl-tRNAs would be recognized by the catalytic pocket of ItaT. The detailed mechanism of the specificities of ItaT is discussed below.

Overall structure of ItaT {#SEC3-4}
-------------------------

The amino acid sequence alignment of ItaT with the closely related GNAT family toxins revealed that G115 is located in the putative acetyl-CoA (Ac-CoA) binding sites ([Supplementary Figure S3](#sup1){ref-type="supplementary-material"}), and the mutations of the corresponding glycine to the aspartic acid in other GNAT toxins, such as AtaT, abolished the toxic activity *in vivo* ([@B16]). Thus, to understand the mechanism for the acetylation of a specific group of aminoacyl-tRNAs by ItaT, the ItaT(G115D) mutant protein was overexpressed in *E. coli* and crystallized, and the structure was determined.

The crystal belongs to the space group *P*2~1~ and contains two dimer forms of ItaT in the asymmetric unit. The initial phase was determined by molecular replacement, using a homology model of ItaT constructed from the structure of *K. pneumoniae* KacT ([@B18]) as the search model. The structure was model-built and refined to an *R* factor of 23.7% (*R*~free~ = 29.6%) at 2.8 Å resolution. The details of the crystallographic data collection and refinement statistics are provided in Table [1](#tbl1){ref-type="table"}.

###### 

Data collection and refinement statistics

                                ItaT (G115D)
  ----------------------------- ------------------------
  **Data collection**           
  Space group                   *P*2~1~
  Cell dimensions               
  *a*, *b*, *c* (Å)             70.18, 45.22, 120.38
  β (°)                         92.77
  Wavelength (Å)                0.98000
  Resolution (Å)\*              50--2.8 (2.899--2.799)
  No. of measured reflections   260534
  No. of unique reflections     19048
  *R* ~sym~\*                   0.193 (1.866)
  *I* / σ*I* \*                 13.9 (1.5)
  *CC* ~1/2~\*                  99.7 (60.7)
  Completeness (%)\*            99.9 (99.2)
  Redundancy\*                  13.7 (14.0)
  **Refinement**                
  Resolution (Å)                20--2.8
  No. reflections               18977
  *R* ~work~/*R*~free~ (%)      0.2373/0.2958
  No. atoms                     
  Protein                       5518
  Water                         31
  *B*-factors (Å^2^)            
  Protein                       73.00
  Water                         44.35
  R.m.s. deviations             
  Bond lengths (Å)              0.004
  Bond angles (°)               1.00

\*Values in parentheses are for the highest-resolution shell.

ItaT forms a dimer in the crystal, similar to other closely related GNAT toxins such as *S. enterica* Typhimurium TacT, *K. pneumoniae* KacT and *E. coli* AtaT ([@B9],[@B15],[@B18]) (Figure [4A](#F4){ref-type="fig"}). The two subunits of the ItaT dimer interact with each other through hydrogen-bond and hydrophobic interactions (Figure [4B](#F4){ref-type="fig"}). H125 in α3 of one subunit forms a hydrogen bond with the main chain carbonyl oxygen of A132 in α3 of the other subunit. I129, A132 and L133 in α3 of one subunit interact with I129, A132 and L133 in the other subunit through hydrophobic interactions. N51 and D53 in α1 also form hydrogen-bonds with K136 in the loop between α3 and β5 in the other subunit. The topology of the ItaT molecule adopts a GNAT fold ([@B30]), consisting of a mixed α/β fold with five α-helices and six β-strands, as also observed in the structures of closely related toxins ([@B30]) (Figure [4C](#F4){ref-type="fig"}, [Supplementary Figure S3](#sup1){ref-type="supplementary-material"}). The Ac-CoA binding site of ItaT is quite homologous to those of other GNAT toxins. Ac-CoA was modeled in this site in the ItaT(G115D) structure (Figure [4D](#F4){ref-type="fig"}). The conserved Ac-CoA binding motif, (Q/RxxGxG/A), resides in the loop between β4 and α3. G115, which was mutated to D115 for crystallization, resides in the loop. Thus, the G115D mutation in ItaT prevents Ac-CoA binding to the pocket, and thereby inhibits the toxicity of ItaT.

![Overall structure of ItaT. (**A**) Ribbon model of the ItaT dimer. ItaT1 and ItaT2 are colored green and cyan, respectively. Amino acid residues 1--8 and 1--9 were not modeled in the structures of ItaT1 and ItaT2, respectively. (**B**) Interface between two ItaT molecules in the ItaT dimer. The subunits are colored as in (A). (**C**) Comparison of the structure of ItaT with those of *E. coli* AtaT and *S. enterica* Typhimurium TacT bound with AcCoA. The AcCoA molecule is depicted by a stick model ([@B9],[@B15]). (**D**) Acetyl-CoA (Ac-CoA) binding site in ItaT. The Ac-CoA molecule was modeled in the structure and is depicted by a stick model.](gkaa487fig4){#F4}

Possible aminoacyl moiety binding site in ItaT catalytic pocket {#SEC3-5}
---------------------------------------------------------------

To identify the binding site of the aminoacyl moiety of aminoacyl-tRNAs in the catalytic pocket of ItaT, the ItaT structure was superimposed onto the structure of the protein N-terminal acetyltransferase, NatF (also named Naa60), complexed with a bisubstrate analog, CoA-Ac-MKAV ([@B33]).

NatF belongs to the GNAT protein family and catalyzes the N-terminal acetylation of transmembrane proteins ([@B34]). CoA-Ac-MKAV represents the transition analog of the acetyl reaction of the N-terminal amino group of the MKAV peptide, using Ac-CoA as an acetyl donor ([@B33]). In the acetylation of the N-terminal amino group of protein by NatF, the N-terminal amino group of the protein nucleophilically attacks the acyl-carbon of the acetyl group of Ac-CoA. Y150 in NatF acts as a general acid that donates a proton to the sulfur of the tetrahedral intermediate of the reaction, and promotes the release of the acetylated product ([@B33],[@B35]). The amino acid sequence alignment of NatF and ItaT revealed the highly homologous catalytic sites, including the Ac-CoA binding sites (Figure [5A](#F5){ref-type="fig"}). G115, the Ac-CoA interacting residue, and Y150 in ItaT superimposed well onto the corresponding G113 and Y150 in NatF, respectively (Figure [5B](#F5){ref-type="fig"}). Thus, Y150 in ItaT also acts as a general acid for the acetylation of the α-amino group of aminoacyl-tRNAs. Consistent with this observation, *in vivo* toxicity assays of ItaT and its mutants demonstrated that ItaT with Y150F or G115D had reduced toxic activities (Figure [5C](#F5){ref-type="fig"}, [D](#F5){ref-type="fig"}), and the hydroxyl group of Tyr150 is important for catalysis.

![Possible aminoacyl moiety binding site in ItaT. (**A**) Superimposition of the structure of ItaT (green) onto that of NatF complexed with the bisubstrate analog, CoA-Ac-MKAV ([@B33]), depicted by a stick model. (**B**) Detailed view of the structure of the active pocket of ItaT complexed with CoA-Ac-MKAV, from the structure of NatF complexed with the analog in (A). For clarity, the structure of NatF was omitted. (**C**) The killing activities of ItaT variants with mutations in Ac-CoA binding sites *in vivo*, as in Figure [1A](#F1){ref-type="fig"}. (**D**) Growth curves of *E. coli* MG1655 transformed pBAD33-ItaT and its variants in (C), in LB containing 50 μg/ml chloramphenicol and 0.1% (w/v) arabinose at 37°C. (**E**) The killing activities of ItaT variants with mutations in the putative aminoacyl moiety binding site *in vivo*. (**F**) Growth curves of *E. coli* MG1655 transformed with pBAD33-ItaT and its variants in (E). **(G**) The relative acetylation activities of ItaT variants (wild-type ItaT was taken as 1.0) under standard conditions. The reaction mixtures were incubated at 37°C for 1 h. The bars in the graphs are SD of more than three independent experiments.](gkaa487fig5){#F5}

The superimposition also identified the possible aminoacyl-moiety binding site in the ItaT catalytic pocket (Figure [5B](#F5){ref-type="fig"}). In the superimposition, the side chain of the methionine of CoA-Ac-[M]{.ul}KAV in the NatF complex structure resides in the proximity of the hydrophobic residues V36, I37, F40 and M102 of ItaT. As described, ItaT acetylates Ile-tRNA^Ile^, Val-tRNA^Val^ and Met-tRNA^Met^, aminoacyl-tRNAs charged with hydrophobic amino acids, *in vivo* and *in vitro* (Figures [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}). Thus, these hydrophobic residues would interact with the side chain of the aminoacyl moiety of aminoacyl-tRNAs. The V36D/I37D and V36G/I37G ItaT mutants lacked toxicities *in vivo* (Figure [5E](#F5){ref-type="fig"}, [F](#F5){ref-type="fig"}). The V36A/V37A mutations in ItaT also reduced the toxicity *in vivo*, although the effects were smaller than the V36D/I37D or V36G/I37G mutation. Consistent with these results, the V36D/I37D, V36G/I37G and V36A/I37A mutations of ItaT all reduced the acetylation efficiency toward Ile-tRNA^Ile^ isoacceptors *in vitro*, to extents of \<5% of wild type ItaT (Figure [5G](#F5){ref-type="fig"}). The F40A and M102A mutations in ItaT also reduced the toxicity of ItaT *in vivo*, and the M102R mutation had greater effects on the reduction of ItaT toxicity *in vivo* (Figure [5E](#F5){ref-type="fig"}, [F](#F5){ref-type="fig"}). Altogether, these results suggest that the hydrophobic side chains of the aminoacyl moieties of aminoacyl-tRNAs (Ile-tRNA^Ile^, Val-tRNA^Val^ and Met-tRNA^Met^) would be recognized by these hydrophobic residues in the active pocket of ItaT.

Possible tRNA binding residues in ItaT {#SEC3-6}
--------------------------------------

The electrostatic potential surface of the ItaT dimer revealed the highly biased distribution of charged residues. The positively charged area is distributed on α1 (K39, R42, K46, K47 and R50) in one subunit and α2 (K80 and R82) in another subunit (Figure [6A](#F6){ref-type="fig"}) In the closely related AtaT, the dimer formation is required for acetylation activity and toxicity of AtaT, and it was suggested that the dimer formation is required for tRNA binding ([@B16]) (Figure [6B](#F6){ref-type="fig"}). When L133 residues located at the dimer interface of dimeric ItaT (Figure [4B](#F4){ref-type="fig"}) was mutated (L133E), the ItaT toxicity was reduced (Figure [6C](#F6){ref-type="fig"}). Thus, ItaT dimer formation would be also required for tRNA binding and the positively charged residues in α1 in one subunit and α2 in another subunit would interact with tRNA. In consistent with this notion, the K46A/K47A and K80A mutations in ItaT slightly reduced the toxicities of ItaT in liquid medium, and the K46A/K47A mutations in ItaT slightly reduced the toxicity and on the plate (Figure [6D](#F6){ref-type="fig"}).

![Possible RNA binding region in ItaT. (**A**) Electrostatic potential of the dimer surface of ItaT. The clustered positively charged residues on α1 in one subunit, enclosed in the dotted box, are highlighted on the right. Positively and negatively charged areas are colored blue and red, respectively. (**B**) Electrostatic potential of the AtaT dimer. The positively charged region toward the Ac-CoA binding pocket spans across the dimer interface. tRNA binding model onto the AtaT dimer. (**C**) The killing activity of ItaT variant with L133E mutation in the dimer interface *in vivo*, as in Figure [1A](#F1){ref-type="fig"} (upper panel). Growth curves of *E. coli* MG1655 transformed pBAD33-ItaT and L133E variant, in LB containing 50 μg/ml chloramphenicol and 0.2% (w/v) arabinose at 37°C (lower graph). (**D**) The killing activities of ItaT variants with mutations in the positively charged area *in vivo*, as in (C) (upper panel). Growth curves of *E. coli* MG1655 transformed pBAD33-ItaT and its variants in upper panel, as in (C) (lower left graph), and the magnified view (lower right graph). The bars in the graphs are SD of more than three independent experiments.](gkaa487fig6){#F6}

DISCUSSION {#SEC4}
==========

ItaT, recently identified in the *Escherichia coli* HS strain, reportedly acetylates the α-amino group of the aminoacyl-moiety of Ile-tRNA^Ile^ isoacceptors specifically, and inhibits protein synthesis *in vitro* ([@B11]). In this study, to clarify the molecular mechanism by which ItaT specifically targets Ile-tRNA^Ile^ isoacceptors for acetylation, we analyzed the structure and functions of ItaT.

The LC/MS analysis of the *in vivo* target aminoacyl-tRNAs of ItaT for acetylation showed that, in addition to the Ile-tRNA^Ile^ isoacceptors, significant fractions of the Val-tRNA^Val^ and Met-tRNA^Met^ isoacceptors are acetylated by the action of ItaT *in vivo* (Figure [2B](#F2){ref-type="fig"}, [C](#F2){ref-type="fig"}). The acetylation of these aminoacyl-tRNAs *in vivo* is quite rapid. By fifteen minutes after ItaT induction, 60--80% of these aminoacyl-tRNAs are acetylated *in vivo*. Consistent with the *in vivo* observations, the *in vitro* acetylation reactions of various aminoacyl-tRNAs showed that, in addition to the Ile-tRNA^Ile^ isoacceptors, Val-tRNA^Val^ and Met-tRNA^Met^ isoacceptors were acetylated significantly *in vitro*, although the acetylation efficiency of Ile-tRNA^Ile^ was greater than those of the Val-tRNA^Val^ or Met-tRNA^Met^ isoacceptors (Figure [3A](#F3){ref-type="fig"}, [B](#F3){ref-type="fig"}). Further, the Ala-tRNA^Ala^ and Phe-tRNA^Phe^ isoacceptors were minimally acetylated *in vivo* and *in vitro* (Figures [2C](#F2){ref-type="fig"} and [3A](#F3){ref-type="fig"}, [B](#F3){ref-type="fig"}), and the Leu-tRNA^Leu^ isoacceptor was barely acetylated *in vitro* (Figure [3A](#F3){ref-type="fig"}, [B](#F3){ref-type="fig"}). Thus, the specificity of ItaT for the substrate aminoacyl-tRNAs is broader than initially reported.

The claim in the recent study reporting the specific acetylation of Ile-tRNA^Ile^ isoacceptors by ItaT was based on the observation that ItaT caused ribosome stalling at the isoleucine codons in model mRNAs during translation *in vitro*, while the translation of a specific mRNA without an isoleucine codon was not affected by ItaT *in vitro* ([@B11]). Our *in vitro* analysis demonstrated that Ile-tRNA^Ile^ isoacceptors are more efficiently acetylated than Val-tRNA^Val^ or Met-tRNA^Met^ isoacceptors *in vitro* (Figure [3A](#F3){ref-type="fig"}, [B](#F3){ref-type="fig"}). Thus, it is likely that only the effects of the acetylation of Ile-tRNA^Ile^ were observed under the conditions used for the reported assays, and the effects of the acetylation of Val-tRNA^Val^ or Met-tRNA^Met^ isoacceptors could not have been detected.

The structural analysis of ItaT (Figure [4](#F4){ref-type="fig"}) and the comparison of the ItaT structure with the structure of NatF complexed with the bisubstrate analog (Figure [5A](#F5){ref-type="fig"}) identified the hydrophobic residues (V36, I37, F40 and M102) in ItaT that possibly interact with the side chain of the aminoacyl-moiety of aminoacyl-tRNAs (Figure [5B](#F5){ref-type="fig"}). In particular, V36 and I37 would be important for the toxicity of ItaT *in vivo* and the acetylation of Ile-tRNA^Ile^*in vitro* (Figure [5E](#F5){ref-type="fig"}, [F](#F5){ref-type="fig"}, [G](#F5){ref-type="fig"}). Thus, these hydrophobic residues would constitute the aminoacyl moiety binding pocket.

The substrate specificities of ItaT *in vivo* and *in vitro*, as described above (Figures [2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}), collectively suggest that the specificity of ItaT could be explained by the side chain structure of the aminoacyl moiety of the substrate aminoacyl-tRNA (Figure [3C](#F3){ref-type="fig"}). The shape and size of the aminoacyl moiety binding pocket in ItaT, in which V36, I37, F40 and M102 compose the wall, would be most suitable for the accommodation of the side chain of isoleucine. The branched methyl group (-Cγ1H~3~) from the Cβ position and the ethyl group (-Cγ2H~2~-CδH~3~) in isoleucine (Figure [3C](#F3){ref-type="fig"}) would snugly fit in the pocket. Valine also has a methyl group (-C~γ2~H~3~) at the Cβ-position, and the ethyl group (-CγH~2~-CδH~3~) in isoleucine is replaced with a methyl group (-Cγ2H~3~). The side chain of valine can be accommodated in the pocket, but the hydrophobic interaction between the side chain of valine and the pocket in ItaT would be weaker than that between isoleucine and the pocket. Methionine lacks the branched methyl group at the Cβ-position, and the methyl group (-CδH~3~) in isoleucine is replaced with -Sδ-CϵH~3~. Thus, the hydrophobic interactions between the methionine side chain and the pocket would become even weaker. These observations can explain the order of the acetylation efficiencies of Ile-tRNA^Ile^, Val-tRNA^Val^ and Met-tRNA^Met^ by ItaT *in vitro* (Figure [3A](#F3){ref-type="fig"}, [B](#F3){ref-type="fig"}). Leucine lacks the branched methyl group (-CH~3~) at the Cβ position, and instead has two methyl (-CδH~3~) groups at the Cγ position. One of the methyl groups branching from the Cγ position would not be accommodated in the pocket of ItaT and would sterically clash with it; thereby, Leu-tRNA^Leu^ would not be a good substrate for acetylation by ItaT. Further, alanine is too small to snugly fit into the hydrophobic pocket of ItaT, and phenylalanine is too big and sterically clashes with the pocket. Thus, Ala-tRNA^Ala^ and Phe-tRNA^Phe^ are also poor substrates of ItaT. The molecular mechanism observed in the selection of substrate aminoacyl-tRNAs by ItaT is similar to those observed in the aminoacyl-tRNA protein transferases, such as leucyl/phenylalanyl-tRNA-protein transferase ([@B36],[@B37]), in that the size and shape of the hydrophobic pocket of the enzyme select the specific group of aminoacyl tRNAs as substrates.

As compared with the electrostatic potentials of other closely related toxins, such as AtaT, the distributions of the positively charged areas in ItaT are distinct from those of AtaT (Figure [6B](#F6){ref-type="fig"}). The previous tRNA docking model onto AtaT ([@B16]) showed that the positively charged areas between the two subunits interact with the acceptor stem (Figure [6B](#F6){ref-type="fig"}), and the mutations of the basic residues reduced the toxicity of AtaT *in vivo* ([@B15]). AtaT reportedly acetylated the initiator Met-tRNA^Met^ (Met-tRNAf^Met^) specifically, but not the elongator Met-tRNA^Met^ (Met-tRNAm^Met^), *in vitro* ([@B10]), implying that AtaT would recognize some sequential or structural features of the tRNA^Met^ acceptor helix, rather than the aminoacyl-moiety. On the other hand, as revealed in this study, ItaT recognizes the Ile-tRNA^Ile^, Val-tRNA^Val^ Met-tRNAf^Met^ and Met-tRNAm^Met^ isoacceptors. There are no apparent shared sequences in their acceptor stem regions, except for the A73C74C75A76 sequence ([Supplementary Figure S4](#sup1){ref-type="supplementary-material"}). The discriminator bases at position 73 of tRNA^Ala^, tRNA^Phe^ and tRNA^Leu^, are also A73 ([Supplementary Figure S4](#sup1){ref-type="supplementary-material"}). Thus, the A73 of tRNAs would not be positive determinant of the selection of aminoacyl-tRNA for acetylation by ItaT.

The suppression effects on the toxicity of ItaT by the mutations in the positively charged area (Figure [6D](#F6){ref-type="fig"}) are generally smaller than those of the mutations in the putative aminoacyl moiety binding pocket (Figure [5E](#F5){ref-type="fig"}, [F](#F5){ref-type="fig"}). Therefore, the mechanism of the acetylation of specific aminoacyl-tRNAs by ItaT would be mainly governed by the aminoacyl moiety, rather than the tRNA body, and only the top of the acceptor helix or the 3′-part of the tRNA would interact with the basic residues proximal to the catalytic site of ItaT without any sequence specificity. It cannot be excluded that, in addition to the acceptor helix, other region of tRNA might interact with the dimer form of ItaT to enhance the acetylation of specific aminoacyl tRNAs. The elucidation of the exact mechanism of substrate aminoacyl-tRNA recognition by ItaT awaits further structural analyses of ItaT complexed with aminoacyl-tRNAs.

The recently identified Type II GNAT family toxins, which target aminoacyl-tRNAs, have various substrate specificities. However, the molecular mechanism underlying the different aminoacyl-tRNA recognition manners and specificities of these GNAT family toxins is still obscure. Further detailed comparative structural and biochemical analyses of these GNAT toxins would clarify the overall view of the molecular mechanisms of these toxins.

DATA AVAILABILITY {#SEC5}
=================

Coordinates and structure factors for the crystal structure of ItaT(G115D) have been deposited in the Protein Data Bank, under the accession code 7BYY.
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